Test of FDOPA PET scan to evaluate a brain tumor
Part of Cancer clinical trials.
This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 75
- Be able to do usual daily activities (WHO condition score 0–2)
- Have a single (one-area) brain tumor found at first diagnosis that MRI did not show with contrast, suspected to be a low-grade glioma, with biopsy or surgery planned within 6 months after the PET scan
- Have a brain MRI within 3 weeks before joining, using standard sequences (T1, contrast T1, and T2 FLAIR)
- Be covered by a social security plan and have signed informed consent
- Be able to safely have an FDOPA PET scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This study uses special scans (PET and MRI) to look at brain tumors in more detail. It aims to understand tumor metabolism and oxygen levels, which may help guide treatment.
This trial tests a special PET scan tracer (18F-FET) to see if it can help doctors better identify and plan treatment for brain tumors. It may be an option if you are scheduled for surgery for a suspected new glioma.
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
This early-phase study uses a special PET scan plus MRI to help doctors tell apart tumor changes in children with aggressive gliomas. It may help find whether treatment is working or if the tumor is progressing, while also mapping tumor activity in the brain.
This Phase 2 trial tests a radiation “planning” approach guided by an FDOPA PET scan. It aims to better target glioblastoma tissue in people who can’t follow the standard STUPP treatment plan.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.